HCL-001

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameHCL-001
Drug Alias NameHCL001HCL-001
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Liver-derivedCell and gene therapy > Cell therapy > Somatic cell > Hepatocytes therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsDecompensated Liver CirrhosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Huicun Medical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesRenji Hospital Affiliated To Shanghai Jiaotong University School Of MedicineShanghai Huicun Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDecompensated Liver CirrhosisLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A